Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A23695 | 23558563 | Dig Dis Sci | Iron overload causes oxidative stress and impaired insulin signaling in AML-12 hepatocytes. | 2013 | Details |
| A23696 | 23558065 | Hepatobiliary Pancreat Dis Int | Therapeutic approaches to non-alcoholic fatty liver disease: past achievements and future challenges. | 2013 | Details |
| A23697 | 23557879 | Nutr Metab Cardiovasc Dis | The fatty liver index is associated with increased mortality in subjects referred to coronary angiography. | 2013 | Details |
| A23699 | 23556042 | World J Hepatol | Silymarin in non alcoholic fatty liver disease. | 2013 | Details |
| A23702 | 23554890 | PLoS One | Oral probiotic microcapsule formulation ameliorates non-alcoholic fatty liver disease in Bio F1B Golden Syrian hamsters. | 2013 | Details |
| A23706 | 23548993 | Tumori | Linking nonalcoholic fatty liver disease to hepatocellular carcinoma: from bedside to bench and back. | 2013 | Details |
| A23711 | 23546700 | Dig Dis Sci | The prevalence and clinical correlates of nonalcoholic fatty liver disease (NAFLD) in African Americans: the multiethnic study of atherosclerosis (MESA). | 2013 | Details |
| A23715 | 23544853 | Metab Syndr Relat Disord | Effects of sitagliptin on nonalcoholic fatty liver disease in diet-induced obese rats. | 2013 | Details |
| A23724 | 23534297 | Med Pregl | [Cardiovascular disease risk factors in patients with non-alcoholic fatty liver disease]. | 2013 | Details |
| A23725 | 23532271 | Braz J Med Biol Res | Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver. | 2013 | Details |
| A23728 | 23529597 | Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz | [Non-alcoholic fatty liver disease in obese children and adolescents]. | 2013 | Details |
| A23732 | 23525389 | J Ultrasound Med | Targeted hepatic sonography during clinic visits for detection of fatty liver in overweight children: a pilot study. | 2013 | Details |
| A23734 | 23522007 | Psychol Med | Elevated alanine aminotransferase independently predicts new onset of depression in employees undergoing health screening examinations. | 2013 | Details |
| A23741 | 23516571 | PLoS One | Systems biology elucidates common pathogenic mechanisms between nonalcoholic and alcoholic-fatty liver disease. | 2013 | Details |
| A23742 | 23516172 | World J Gastrointest Pharmacol Ther | Inhibition of apoptosis in the management of nonalcoholic fatty liver disease. | 2013 | Details |
| A23745 | 23514731 | Diabetes Care | Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver. | 2013 | Details |
| A23746 | 23512965 | Obesity (Silver Spring) | Metabolomic signatures in lipid-loaded HepaRGs reveal pathways involved in steatotic progression. | 2013 | Details |
| A23747 | 23512881 | Obesity (Silver Spring) | A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population. | 2013 | Details |
| A23752 | 23510120 | Hepatol Res | Clinical usefulness of non-protein respiratory quotient measurement in non-alcoholic fatty liver disease. | 2013 | Details |
| A23758 | 23507799 | Nat Rev Gastroenterol Hepatol | Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. | 2013 | Details |
| A23762 | 23504985 | Pediatr Obes | Epicardial adipose tissue and cardiometabolic risk factors in overweight and obese children and adolescents. | 2013 | Details |
| A23763 | 23504926 | Hepatology | Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial). | 2013 | Details |
| A23768 | 23500152 | J Hepatol | Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome. | 2013 | Details |
| A23770 | 23497552 | BMC Res Notes | Morphological and metabolic determinants of nonalcoholic fatty liver disease in obese youth: a pilot study. | 2013 | Details |
| A23772 | 24843641 | J Diabetes Investig | Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas. | 2013 | Details |
| A23775 | 23492103 | Gut | Molecular interplay between Δ5/Δ6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis. | 2013 | Details |
| A23778 | 23488792 | J Gastroenterol Hepatol | Antigen peptide transporter 1 is involved in the development of fructose-induced hepatic steatosis in mice. | 2013 | Details |
| A23781 | 23485520 | J Hepatol | The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. | 2013 | Details |
| A23786 | 23482247 | World J Gastroenterol | Fructose as a key player in the development of fatty liver disease. | 2013 | Details |
| A23791 | 23478717 | Nutr Hosp | Influence of G1359A polimorphysm of the cannabinoid receptor gene (CNR1) on insulin resistance and adipokines in patients with non alcoholic fatty liver disease. | 2013 | Details |
| A23792 | 23478246 | Minerva Gastroenterol Dietol | Liver steatosis in celiac disease: the open door. | 2013 | Details |
| A23793 | 23478245 | Minerva Gastroenterol Dietol | Management of non-alcoholic fatty liver disease. | 2013 | Details |
| A23795 | 23477499 | Antioxid Redox Signal | Peroxiredoxin 4 protects against nonalcoholic steatohepatitis and type 2 diabetes in a nongenetic mouse model. | 2013 | Details |
| A23796 | 23476686 | Evid Based Complement Alternat Med | Managing the combination of nonalcoholic Fatty liver disease and metabolic syndrome with chinese herbal extracts in high-fat-diet fed rats. | 2013 | Details |
| A23801 | 23466642 | Horm Res Paediatr | Nonalcoholic fatty liver disease in prepubertal children born small for gestational age: influence of rapid weight catch-up growth. | 2013 | Details |
| A23806 | 23458891 | Nat Rev Gastroenterol Hepatol | NAFLD in Asia--as common and important as in the West. | 2013 | Details |
| A23812 | 23453039 | Metabolism | Involvement of regucalcin in lipid metabolism and diabetes. | 2013 | Details |
| A23813 | 23452341 | Br J Clin Pharmacol | The hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intake. | 2014 | Details |
| A23814 | 23452186 | Clin Microbiol Infect | Obesity, non-alcoholic fatty liver disease, and atherothrombosis: a role for the intestinal microbiota? | 2013 | Details |
| A23815 | 23452163 | Clin Microbiol Infect | Gut microbiota and non-alcoholic fatty liver disease: new insights. | 2013 | Details |
| A23817 | 23451176 | PLoS One | Differential intrahepatic phospholipid zonation in simple steatosis and nonalcoholic steatohepatitis. | 2013 | Details |
| A23827 | 25755466 | J Clin Exp Hepatol | Patients with Nonalcoholic Fatty Liver Disease (NAFLD) have Higher Oxidative Stress in Comparison to Chronic Viral Hepatitis. | 2012 | Details |
| A23834 | 23439771 | Diabetes Metab J | Increased selenoprotein p levels in subjects with visceral obesity and nonalcoholic Fatty liver disease. | 2013 | Details |
| A23836 | 23439261 | J Hepatol | The liver diseases of lipodystrophy: the long-term effect of leptin treatment. | 2013 | Details |
| A23838 | 23435355 | Biochem Pharmacol | Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway. | 2013 | Details |
| A23840 | 23433458 | Adv Pharmacol | Eicosanoids in metabolic syndrome. | 2013 | Details |
| A23841 | 23432982 | Arab J Gastroenterol | Relationship between non-alcoholic fatty liver disease and kidney function: a communication between two organs that needs further exploration. | 2012 | Details |
| A23842 | 23432843 | Liver Int | GLP-1 analogue prevents NAFLD in ApoE KO mice with diet and Acrp30 knockdown by inhibiting c-JNK. | 2013 | Details |
| A23845 | 23431468 | ISRN Endocrinol | Roles for PI3K/AKT/PTEN Pathway in Cell Signaling of Nonalcoholic Fatty Liver Disease. | 2013 | Details |
| A23846 | 23431426 | J Obes | Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance? | 2013 | Details |
| A23847 | 23431294 | Int J Endocrinol | Hepatic steatosis and thyroid function tests in overweight and obese children. | 2013 | Details |
| A23850 | 23430039 | World J Gastroenterol | What is the role of adiponectin in obesity related non-alcoholic fatty liver disease? | 2013 | Details |
| A23851 | 23426824 | J Pediatr Endocrinol Metab | Obesity, insulin resistance, and the risk of an elevated alanine aminotransferase activity in the Korean adolescent population. | 2012 | Details |
| A23852 | 23426822 | J Pediatr Endocrinol Metab | Relationship between left ventricular mass and carotid intima media thickness in obese adolescents with non-alcoholic fatty liver disease. | 2012 | Details |
| A23854 | 23426707 | Exp Clin Endocrinol Diabetes | Liver lipocalin 2 expression in severely obese women with non alcoholic fatty liver disease. | 2013 | Details |
| A23858 | 23424927 | Rev Prat | [Treatment of nonalcoholic steatohepatitis]. | 2012 | Details |
| A23861 | 23424924 | Rev Prat | [Epidemiology and natural history of nonalcoholic fatty liver disease]. | 2012 | Details |
| A23863 | 23420151 | Clinics (Sao Paulo) | Dietary patterns in Brazilian patients with nonalcoholic fatty liver disease: a cross-sectional study. | 2013 | Details |
| A23865 | 23419734 | Nutr Metab Cardiovasc Dis | Association of hepatic insulin resistance indexes to nonalcoholic fatty liver disease and related biomarkers. | 2013 | Details |
| A23866 | 23419204 | Atherosclerosis | Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis. | 2013 | Details |
| A23867 | 23418085 | Obesity (Silver Spring) | Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity. | 2013 | Details |
| A23874 | 23411507 | Endocr J | High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome. | 2013 | Details |
| A23875 | 23410526 | Biochim Biophys Acta | Prevention and reversal of hepatic steatosis with a high-protein diet in mice. | 2013 | Details |
| A23881 | 23405890 | Clin Endocrinol (Oxf) | Low serum potassium level is associated with nonalcoholic fatty liver disease and its related metabolic disorders. | 2013 | Details |
| A23887 | 23402081 | Acta Gastroenterol Belg | Pleiotropic functions of bile acids mediated by the farnesoid X receptor. | 2012 | Details |
| A23888 | 23401753 | J Obes | Altered hepatic lipid metabolism contributes to nonalcoholic fatty liver disease in leptin-deficient Ob/Ob mice. | 2013 | Details |
| A23896 | 23397556 | Semin Thromb Hemost | Diagnosis and management of nonalcoholic fatty liver disease and its hemostatic/thrombotic and vascular complications. | 2013 | Details |
| A23898 | 23397118 | J Gastroenterol | Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. | 2013 | Details |
| A23903 | 23394097 | Curr Pharm Des | Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment. | 2013 | Details |
| A23904 | 23394096 | Curr Pharm Des | Classical and innovative insulin sensitizing drugs for the prevention and treatment of NAFLD. | 2013 | Details |
| A23906 | 23394094 | Curr Pharm Des | Antioxidant therapy and drugs interfering with lipid metabolism: could they be effective in NAFLD patients? | 2013 | Details |
| A23908 | 23394092 | Curr Pharm Des | Pathophysiology of NASH: perspectives for a targeted treatment. | 2013 | Details |
| A23909 | 23394091 | Curr Pharm Des | Epidemiology and natural history of patients with NAFLD. | 2013 | Details |
| A23911 | 23392905 | Clin Chem Lab Med | Serum carcinoembryonic antigen is associated with non-alcoholic fatty liver disease in healthy Korean non-smokers. | 2013 | Details |
| A23916 | 23390892 | Atherosclerosis | Sex-influenced association of nonalcoholic fatty liver disease with coronary heart disease. | 2013 | Details |
| A23918 | 23390127 | Hepatology | Dietary fructose in nonalcoholic fatty liver disease. | 2013 | Details |
| A23924 | 23385644 | J Mol Med (Berl) | Lack of kinin B₁ receptor potentiates leptin action in the liver. | 2013 | Details |
| A23936 | 23373292 | Vopr Kurortol Fizioter Lech Fiz Kult | [Balneotherapeutics of non-alcoholic fatty liver disease with the use of the Essentuki-type drinking mineral waters]. | 2013 | Details |
| A23939 | 23370355 | Biol Pharm Bull | A novel inhibitor of stearoyl-CoA desaturase-1 attenuates hepatic lipid accumulation, liver injury and inflammation in model of nonalcoholic steatohepatitis. | 2013 | Details |
| A23941 | 23369196 | Clin Exp Pharmacol Physiol | Relationship between serum osteocalcin levels and non-alcoholic fatty liver disease in Chinese men. | 2013 | Details |
| A23943 | 23367495 | J Clin Res Pediatr Endocrinol | Association between insulin resistance and oxidative stress parameters in obese adolescents with non-alcoholic fatty liver disease. | 2013 | Details |
| A23944 | 23367494 | J Clin Res Pediatr Endocrinol | High-sensitivity C-reactive protein levels and metabolic disorders in obese and overweight children and adolescents. | 2013 | Details |
| A23946 | 23363012 | Ann N Y Acad Sci | Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. | 2013 | Details |
| A23952 | 23355910 | World J Hepatol | Is nonalcoholic fatty liver disease the hepatic expression of the metabolic syndrome? | 2012 | Details |
| A23954 | 23353867 | J Hepatol | Post-transcriptional activation of PPAR alpha by KLF6 in hepatic steatosis. | 2013 | Details |
| A23955 | 23353640 | Clin Gastroenterol Hepatol | External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. | 2013 | Details |
| A23959 | 23351585 | J Clin Lipidol | Genetic determinants of cardiometabolic risk: a proposed model for phenotype association and interaction. | 2012 | Details |
| A23962 | 23348005 | Toxicol In Vitro | Quercetin ameliorate insulin resistance and up-regulates cellular antioxidants during oleic acid induced hepatic steatosis in HepG2 cells. | 2013 | Details |
| A23963 | 23347840 | Clin Res Hepatol Gastroenterol | Non-alcoholic steatohepatitis in morbidly obese patients. | 2013 | Details |
| A23966 | 23346150 | Hepat Mon | Predictive factors for ultrasonographic grading of nonalcoholic Fatty liver disease. | 2012 | Details |
| A23967 | 23346097 | Front Genet | Molecular Interactions between NAFLD and Xenobiotic Metabolism. | 2013 | Details |
| A23968 | 23344895 | Pediatr Cardiol | Subclinical hypothyroidism as a risk factor for the development of cardiovascular disease in obese adolescents with nonalcoholic fatty liver disease. | 2013 | Details |
| A23969 | 23340336 | Br J Nutr | Carbohydrate quality is not associated with liver enzyme activity and plasma TAG and HDL concentrations over 5 years in an older population. | 2013 | Details |
| A23970 | 23339953 | J Hepatol | Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice. | 2013 | Details |
| A23972 | 23334462 | Diabetologia | Adipose tissue is inflamed in NAFLD due to obesity but not in NAFLD due to genetic variation in PNPLA3. | 2013 | Details |
| A23975 | 23332087 | Hepatol Res | Liver and diabetes. A vicious circle. | 2013 | Details |
| A23978 | 23329754 | J Pediatr Endocrinol Metab | A decrease in fasting FGF19 levels is associated with the development of non-alcoholic fatty liver disease in obese adolescents. | 2012 | Details |
| A23979 | 23329465 | Drugs | Nonalcoholic fatty liver disease: current issues and novel treatment approaches. | 2013 | Details |
| A23989 | 23324907 | Herz | Increased H-FABP concentrations in nonalcoholic fatty liver disease. Possible marker for subclinical myocardial damage and subclinical atherosclerosis. | 2013 | Details |
| A23994 | 23320150 | J Obes | Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists? | 2012 | Details |